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Summary 
To directly study the biological properties of purified hematopoietic  colony-forming  cell precursors, 
cells with a CD34 + CD45RA  l~ CD71 I~ phenotype were purified from human bone marrow 
using density separation and fluorescence-activated call sorting, and were cultured in serum-free 
culture medium supplemented with various cytokines. In the presence of interleukin 3 (IL-3), 
Ib6,  erythropoietin,  and  mast  cell  growth  factor  (a  c-kit  ligand),  cell  numbers increased 
approximately  10~-fold over  a  period of 4  wk,  and  the percentage of calls that  expressed 
transferrin receptors (CD71) increased from <:0.1% at day 0 to >99% at day 14. Interestingly, 
the absolute number of CD34 + CD711~ cells did not change during culture. When CD34 + 
CD711~ cells were sorted from expanded cultures and recultured, extensive cell production was 
repeated, again without significant  changes in the absolute number of cells with the CD34 + 
CD71 l~ phenotype that were used to initiate the (sub)cultures.  These results document that 
primitive hematopoietic cells can generate progeny without an apparent decrease in the size of 
a precursor cell pool. 
T 
he formation of blood cells in the bone marrow is the 
result of proliferation and differentiation of hematopoi- 
etic cells that differ widely in their proliferative and differen- 
tiation potential. Lineage-restricted progenitors as well as 
multi-lineage progenitors are all thought to be derived from 
a  more primitive population of hematopoietic cells,  the 
majority of which are considered to be quiescent during normal 
steady-state  hematopoiesis (1). The study of such cells in 
humans has been hampered by the lack of quantitative assays 
for totipotent human hematopoietic cells, their expected low 
frequency among nucleated bone marrow cells, and difficul- 
ties in obtaining sufficient bone marrow cells for their isola- 
tion in large numbers. As a result, major questions regarding 
the mechanisms of stem cell maintenance, activation, and 
differentiation remain to be answered, despite an increasing 
number of indirect  studies,  implying the role of various 
cytokines and cell-cell interactions in these processes (1-4). 
The identification of the product of the Steel gene (Steel 
factor; mast cell growth factor, MGF; 1 c-kit ligand; stem cell 
factor) as an important regulatory molecule for immature he- 
matopoietic cells (5-7) has increased interest in the possibility 
1 Abbreviations used in thispaper: Epo, crythropoietin; LTC-IC, long-term 
culture initiating cell; MGF, mast cell growth factor. 
of expanding hematopoietic cells in vitro for a variety of clinical 
applications. Indeed, several  recent papers have described studies 
with purified hematopoietic  cells from mice (8, 9) and humans 
(2, 10, 11) that were cultured in the presence of Steel factor 
and other growth factors. All these studies have documented 
large increases in the production of progenitor cells, but little 
or no increase in the numbers of the most primitive hemato- 
poietic cells. These results suggest that such cells are either 
unresponsive to Steel factor or display unusual properties that 
concomitantly prevent expansion and avoid depletion. We 
describe here that primitive hematopoietic cells from human 
bone marrow  that  participate in  extensive  and  sustained 
production of cells are themselves maintained at constant 
numbers in serum-free cultures containing Steel factor, I1.-6, 
II.-3, and erythropoietin (Epo). 
Materials  and Methods 
mAbs.  IgG1  mAbs specific  for CD34 (8G12 [12]), CD45RA 
(8d2 [D]), CD71 (0KT9 [14]), and glycophorin A (10F7MN [15]) 
were purified  from bybridoma  tissue  culture supernatant  using pro- 
tein A or protein G affanity  chromatography.  8G12 mAbs were la- 
beled with cyanine 5-succinimidylester  as described  (16). Cy5 was 
kindly provided  by Dr. A. S. Waggoner (Carnegie Mellon Univer- 
sity, Pittsburgh, PA). 0KT9 mAbs were labeled  with FITC (F-7250; 
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of 5.0. 8d2 and 10F7MN mAbs were labeled with RPE by mixing 
with,  respectively, monoclonal  IgG1 anti-RPE  antibody  1D3, 
F(ab')2 fragments of rat anti-mouse IgG1, and RPE at a molec- 
ular ratio of 1:1:2:4 as described  (13). 8G12-R.PE  was kindly provided 
by Drs. A. Jackson and L. Terstappen (Becton Dickinson & Co., 
San Jose, CA). 
Bone Marrow Cells.  Heparinized bone marrow was obtained 
from informed and consenting individuals donating  marrow for 
allogeneic transplantation. Low-density cells (<1.077 g/cm  3) were 
isolated using Ficoll-Paque (Pharmada  LKB, Uppsala, Sweden), 
resuspended in Iscove's  medium with 50% FCS and kept overnight 
at 4~  In some experiments, suspensions of bone marrow cells 
(1-3  x  101~  cells total)  retrieved from vertical bodies of organ 
donors were also used (kindly provided by Dr. M. Strong, North 
West Tissue Center, Seattle, WA). These cells were aliquoted and 
frozen in Iscove's  medium containing 2.5% human serum albumin 
and 7.5% DMSO either after density separation using Percoll as 
described (17) or without further manipulation.  Vials of frozen 
marrow cells were rapidly thawed and slowly diluted with Iscove's 
medium containing 0.1 mg/ml DNA-se (type II-S, D4513; Sigma 
Chemical Co.) and 2% FCS. Ceils were then washed once and 
resuspended in Hank's hepes-buffered salt solution containing 2% 
FCS and 0.1%  sodium azide (HFN) for subsequent staining. 
Three-Color Cell Analysis and  Sorting.  Bone  marrow  calls 
(107/ml) were incubated simultaneously  with 8G12-CyS, 8d2-R.PE 
complexes, and 0KT9-FITC at,  respecti~vely,  20, 4 and 1 #g/ml 
for 30 min at 4~  Controls  consisted of single-stained suspen- 
sions and three-color staining with anti-TNP-RPE complexes in- 
stead of 8d2-RPE complexes. Cells were washed twice in HFN 
and resuspended in HFN containing  2/~g/ml propidium iodide 
(10-5264; Sigma Chemical Co.) before sorting. Throughout the pro- 
cedure, cells were kept at 4~  Cells were sorted on a FACStar 
Plus  |  (Becton Dickinson & Co.) equipped with a 5-W argon and 
a 30-roW helium neon laser. Specific  fluorescence of FITC, RPE, 
PI, and Cy5 excited at 488 nm (0.4 W) and 633 nm (30 mW), 
as well as forward and orthogonal light scatter signals, were used 
to establish sort windows. Positivity for each probe was defined 
as fluorescence  that exceeded  99% of controls. Calls were collected 
in serum-free  medium. For phenotypic characterization  of  cells upon 
culture, suspensions of  cells were labeled  with 8G12-CyS, 10F7MN- 
RPE complexes, and 0KTg-FITC. For other resorting experiments 
cultured cells were labeled with 8G12-1LPE and 0KT9-FITC. 
Serum-free Cultures.  The serum-free medium used in this study 
was a modification of serum-free medium described for murine 
erythroid progenitor cells (18). IMDM powder, (17633; Sigma 
Chemical Co.) was stored at  -20~  in 0.177-g aliquots. Single 
aliquots were dissolved in 9.8 ml double-distilled water plus 0.2 
ml 7% (wt/vol) NaHCO3.  A volume of 7.57 ml of this solution 
was used to prepare 10 ml complete serum-free medium by adding 
2.3 ml of an albumin/insulin/transferrin/pen/strep  mixture (see 
below), 50/~1 of 10 mM 2-ME, and 80 #1 of low density lipopro- 
teins (5 mg/ml, L-2139; Sigma Chemical Co.). Complete serum- 
free medium was filter sterilized (0.2/zm) before use and prepared 
fresh from powder for each experiment. The ingredients of the al- 
bumin/insulin/transferrin/pen/strep  mixture  were  prepared  as 
follows. A solution of 20% (wt/vol) of BSA (fraction V, A4503; 
Sigma Chemical Co.) in double-distiUed  water was deionized using 
60 g of AG-501-X8(D) resin (Bio-Rad Laboratories, Richmond, 
CA), filtered and mixed with an equal volume of double-strength 
IMDM (plus bicarbonate) to give a 10% (wt/vol) stock solution, 
which was filter sterilized, and kept at  - 20~  in aliquots. Insulin 
(40205; Collaborative Research, Bedford, MA) was stored in ali- 
quots at I mg/ml in IMDM at  -20~  Human transferrin (iron- 
saturated, 82-343; ICN ImmunoBiological, Costa Mesa, CA) was 
stored in aliquots at 20 mg/ml in IMDM at -20~  A stock solu- 
tion of penicillin (104 U/ml) and streptomycin (5 mg/ml) was also 
kept at  -20~  in aliquots (pen/strep).  To 20 ml of the 10% al- 
bumin solution, 1 ml of pen/strep stock solution, I ml of insulin 
stock solution, and I ml of transferrin stock solution were added 
to obtain BSA/insulin/transferrin/pen/strep  mixture. Aliquots of 
2.3 ml of this mixture were kept at  -20~  to prepare serum-free 
medium as described above. The final concentrations of  various in- 
gredients in serum-free medium were 2% BSA, 10/~g/ml insulin, 
200 #g/ml transferrin, 40/~g/ml low density lipoproteins, 5  x 
10 -s  M  2-ME,  and  pen/strep  (at,  respectively, 102  U  and  50 
/~g/ml). It should be noted that this medium is not truly serum- 
free in that some contamination of the BSA and transferrin prepa- 
rations with serum proteins is to be expected. 
Cultures were initiated in 24-well tissue culture plates (Nunc, 
Kamstrup, Denmark) in serum-free medium at a concentration of 
104 cells/ml at 37~  in a water-saturated atmosphere of 5% COs 
in air. The medium was supplemented with (combinations of) the 
following recombinant human growth factors: IL-6, IL-3, MGF, 
and EPO. Ib6 and MGF were kindly provided by Dr. D. E. Wil- 
liams (Immunex, Seattle,  WA). Tissue culture supcruatants of  trans- 
fected Cos cells containing human IL-3 at 20/zg/ml and human 
EPO at 150 U/ml were provided by colleagues in our laboratory. 
The final concentrations of the various cytokines used in serum- 
free cultures were 20 ng/ml II.,3, 10 ng/ml IL-6, 50 ng/ml MGF, 
and 3 U/ml EPO. Cultures were diluted when the total number 
of cells per well reached confluency at ~10  ~ cells/ml. Every 5-7 d, 
cultures were subjected to half medium change with fresh medium 
and growth factors. After variable time intervals the cells of each 
culture were harvested by pipetting,  spun, and resuspended in a 
small measured volume of serum-free medium. The numbers of 
viable and dead cells were counted in a hemocytometer using trypan 
blue before subsequent studies. For some experiments purified cells 
were cultured in Iscove's medium alone or in medium containing 
10% FCS (A-1111-L; HyClone Labs, Logan, UT). 
Progenitor  Cell Assays.  Clonogenic and long-term culture assays 
were performed as described previously (19), with the exception 
that 20 ng/ml GM-CSF/IL-3 fusion protein  (20) and 50 ng/ml 
human MGF were added to methylcellulose cultures for assays of 
clonogenic cells with purified cells. The total number of clono- 
genie cells present in pooled adherent and nonadherent cell frac- 
tions of 5-wk-old long-term cultures using regular methylcellu- 
lose cultures was used to obtain an estimate of long-term culture 
initiating  cell (LTC-IC) frequency (21). 
Thymidine Incorporation  Assays.  Thymidine incorporation assays 
were  performed  in  96-well round-bottomed microtiter  plates 
(Nunc).  Purified CD34 + CD45RA  1~ CD71  l~ bone marrow cells 
(1,000/well) were cultured for 8 d in 200 #1 serum-free medium 
supplemented with and without growth factors at the concentra- 
tions indicated above. Cells were cultured for the last 6 h in the 
presence of 10/~M [3H]thymidine (2 Ci/mmol, Net-027A; New 
England Nuclear, Boston, MA). Ceils were then harvested on filter 
mats and counted using a scintillation counter (LKB Instruments, 
Turku,  Finland). 
Results 
Resolution of CD34 §  Cells into Functionally Distinct Sub- 
populations by  Correlated CD45RA  and  CD71  (Transferrin 
Receptor) Expression.  The small fraction (1-3% of cells) of 
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Figure 1.  Sr  of CD34 + CD45RA  1~ CD71 l~ cells from organ 
donor bone marrow by flow cytometry. (A) Selection of the light scatter 
window used in all subsequent analyses and sorts, (B) selection of CD34 * 
cells, (C) correlated expression of CD451LA and CD71 of cells in scatter 
window, and (D) correlated expression of CD45RA and CD71 of CD34 + 
cells. The boxed area in D  indicates the criteria used for sdr  l~f 
CD34 + CD45ILAlo  CD71 lo cells among CD34 + cells. All dot plots are 
derived from low-density cells that are propidium iodide (PI) negative. 
l=horescence is plotted on a log scale. 
low-density cells in bone marrow that expresses CD34 can 
be subdivided into distinct subpopulations using antibodies 
against CD45RA  and CD71,  as is shown in Figs.  1 and 2. 
Although  the  relative  size  of the  CD34 §  subpopulations 
defined by CD45RA  and CD71  varied to some extent be- 
tween donors and between bone marrow aspirates (Fig.  2, 
A  and B)  and bone marrow cells from vertebral bodies  of 
cadaveric organ donors (Fig. 2, C  and D), the overall resolu- 
tion of CD34 + cells using this three-color staining strategy 
was very similar and reproducible. Note that the proportion 
of CD34 + cells with a CD34 + CD45RA l~ CD711~ pheno- 
type was higher among gated bone marrow cells from organ 
donors (18.4%  and 8.0%,  respectively in Fig.  2,  C  and D) 
as compared with marrow aspirates (respectively, 4.5%  and 
2.6% in Fig. 2, A  and B). The distribution  of CD34 + cells 
detected by donogenic and long-term culture assays over the 
subpopulations defined by correlated expression of CD45RA 
and CD71 was studied in more detail.  The results of these 
r  are summarized in Table 1. Despite considerable 
variation in the results of these biological assays, a number 
of consistent findings were obtained.  Cells capable of initi- 
ating long-term cultures  (LTC-IC) were highly enriched in 
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Figure 2.  Correlated expression of CD45RA and CD71 on CD34 + 
bone marrow cells. Marrow aspirates from two different donors (A and 
B) and bone marrow calls from two different organ donors (C and D) 
were analyzed. Cells were gated with respect to light scatter properties 
and CD34 expression as shown by the boxed areas in Fig. 1, A and B. 
The windows used to sort CD34 + CD45RAlo CD711o cells are repre- 
sented by the boxed areas in A-D. The thresholds set to discriminate be- 
twcen CD71 lo and CD71 + and CD45RAlo and CD45RA + cells (Table 
1) are those used to create boxed areas in A-D. 
CD34 +  CD45RA 1~ CD711~ cell  fractions,  whereas  CFU- 
GM  and  BFU-E  were  enriched  in  CD34 +  CD45RA + 
CD71 +  and  CD34 +  CD45RA 1~  CD71 +  cell  fractions, 
respectively. This relation between phenotype and function 
was observed irrespective of whether marrow aspirates or ver- 
tebral body bone marrow calls were  studied. 
Survival of CD34 + CD45RA l~ CD7I ~ Cells in Serum-free 
and Serum-containing  Tissue Culture Media.  The survival of 
purified CD34 + CD45RA 1~ CD71 I~ cells in Iscove's medium 
containing  10%  FCS  (22)  and  serum-free  tissue  culture 
medium is shown in Fig. 3. Without addition of exogenous 
growth  factors the  number  of viable cells decreased much 
more rapidly in serum-containing  medium than in serum- 
free medium.  In view of this finding, further studies on the 
functional properties of purified CD34 + CD45RA 1~ CD711~ 
ceils were performed in  serum-free culture  medium. 
+  1o  1o  Induction of Erythropoiesis from CD34  CD45RA  CD71 
Cells.  The effect of IL-6, IL-3, MGF, and Epo in serum-free 
cultures of CD34 + CD45RA I~ CD71 l~ cells from previously 
frozen bone marrow  cells was  studied  using  a  [3H]thymi- 
1503  Lansdorp  and Dragowska Table  1.  Correlated  Expression of CD71 and CD45RA  Allows Separation of Functional Subpopulations of CD34 §  Cells 
BFU-E  CFU-GM  LTC-IC 
Percent*  Frequencyt  Enrich-  Re-  Frequency*  Enrich-  Re-  Frequency*  Enrich-  Re- 
Exp.  Fraction Sorted  sorted  (per  10  s)  ment  covery  (per  105)  ment  covery  (per  2  x  106)  ment  covery 
Bone marrow aspirates: 
1  Unsorted, stained  230  1  100  42  1  100  30 
CD34 + CD45RA  l~ CD71  l~  0.3  1,130  4.9  1.5  500  12  3.6  93,000 
CD34 + CD45RA  1~ CD71 +  0.8  22,630  98  78  2,250  54  43  12,500 
CD34 + CD45RA +  1.1  750  3.2  3.5  750  18  20  0 
2  Unsorted,  stained  -  270  1  100  380  1  100  300 
CD34 + CD45RA  lo CD711~  0.23  1,500  5.6  1.3  2,750  7.2  1.4  96,500 
CD34 + CD45RA  t~ CD71 +  0.54  60,500  224  112  11,130  29  15  21,250 
CD34 + CD34RA +  0.8  500  1.9  1.5  31,250  82  66  11,500 
3  Sorted,  stained  41.0  140  1  100  330  1  100  40 
CD34 + CD45RA  l~ CD71  l~  0.6  0  0  0  250  0.8  0.5  70,250 
CD34 + CD45RAh CD71 +  2.2  10,130  72  158  4,000  12  26  19,500 
CD34 + CD45RA +  3.2  2,250  16  51  16,500  50  160  7,500 
Organ donor bone marrow: 
4  Sorted,  stained  62.2  2,060  1  100  660  1  100  13,300 
CD34 + CD45RA  ~o CD71  lo  3.1  660  0.3  0.9  1,670  2.5  7.8  368,000 
CD34 + CD45RA  1~ CD71 +  8.0  22,340  11  88  12,360  19  152  103,400 
CD34 + CD45RA +  2.5  0  0  0  16,300  25  63  3,600 
5  Sorted,  stained  42.3  1,420  1  100  600  1  100  5,300 
CD34 § CD45RAIo  CD71  to  0.3  1,130  0.8  0.2  660  1.1  0.3  200,000 
CD34 + CD45RAlo CD71 +  2.7  17,800  13  35  9,070  15  41  100,600 
CD34 + CD45RA +  2.5  0  0  0  14,500  24  60  0 
lS  100 
3,1005  930 
417  334 
0  0 
1  100 
322  64 
71  36 
38.6  30 
15  100 
1,7565  1,053 
488  1,014 
188  602 
1  100 
28  87 
7.8  62 
0.3  0.8 
1  100 
38  11 
19  51 
0  0 
* The percentage  of low-density, PI-negative cells in the light scatter window (Fig.  1./1, sorted stained) or the percentage  of cells with the indicated 
phenotype within these gates. 
t The number of colonies per 10  ~ cells (clonogenic assays) or 2  x  106 cells/dish (LTC-IC assays). Results for sorted cell fractions (fewer cells plated) 
were calculated from actual colony counts for comparisons.  The number of colonies present in 5-wk-old long-term cultures  per 2  x  10~ cells plated 
(data  shown) should  be divided by four to derive  at  a more accurate  estimate  of the actual  LTC-IC frequency  (21). 
S The high enrichment/recovery of LTC-IC in these experiments  probably  reflects removal of inhibitory cells present  in unseparated  marrow cells. 
dine incorporation assay (Table 2). Maximal stimulation was 
obtained if all four growth factors were present, and the effect 
of these culture conditions on purified CD34 § CD45RN ~ 
CD71 l~ cells were studied in more detail The total number 
Figure 3.  Survival of purified 
hematopoietic  cells  in  medium 
with and without FCS. Cultures 
fled CD34 + CIM5RA  lo CD7110 
bone  marrow  cells  from  two 
_~  different organ donors in serum- 
cn  free  medium  (F'I)  and  Iscove's 
0~  25  medium  containing  10%  FCS 
]  ~~  (,). The percentage  viable cells 
0  -  ￿9 
0  3  6  9  12  15  (mean  r  SD)  was  determined 
Days  using trypan  blue. 
of cells in such cultures increased rapidly and exponentially 
for a period of up to 20 d  (Fig.  4).  It was calculated that 
for each CD34 + CD45RN ~ CD71  l~ cell, a total of 0.9 and 
3.3  x  106 cells  was recovered for, respectively, BM1  and 
BM2 at day 30 and many thousand-fold more at day 50 (Fig. 
4). This large increase in cell numbers was accompanied by 
marked changes in the overall cell surface phenotype of the 
cultured cells,  as is illustrated for four time points in Fig. 
5. After 3 d in culture, the majority of the cells (99%) were 
still CD34 +, but some cells coexpressed CD71. At day 6 the 
majority of the cells were CD71 + and about half the cells 
were CD34-.  Practically all cells (99%) were CD71 + and 
CD34-  by day 9,  and at day 14 the majority of cells ex- 
pressed glycophorin, indicative of a relatively late erythroid 
differentiation stage (Fig. 5). At day 10 most of the ceils were 
erythroblasts and (pro) normoblasts with a prominent Golgi 
and basophilic to grey cytoplasm upon staining with Giemsa. 
1504  Hematopoiesis  from a Constant Number of Precursor  Cells Table  2.  Combinations of Growth Factors Induce Maximal Stimulation of Purified Hematopoietic Cells 
Condition  BM1  BM2  BM3 
Serum-free medium only  301  +  232  100  _+  0  85  •  12 
IL-3  1,274  _+  263  784  _+  128  1,686  •  174 
IL-6  304  +  232  86  +  8  106  +  16 
MGF  813  _+  407  169  _+ 35  139  •  30 
Epo  91  +  18  85  _+  7  88  +  17 
IL-6  +  MGF  350  _+  31  222  •  23  296  •  7 
IL-3  +  MGF  9,573  •  4,030  3,118  +  297  6,194  •  425 
MGF  +  Epo  410  •  92  222  •  45  266  •  94 
IL-3  +  IL-6  +  MGF  8,209  _+  1,130  5,109  _+ 220  6,160  •  1,824 
IL-6  +  MGF  +  Epo  920  +  228  247  •  33  946  •  314 
IL-3  +  MGF  +  Epo  38,704  •  17,235  7,163  _+  1,205  49,162  •  7,724 
IL-3  +  IL-6  +  MGF  +  Epo  56,264  •  12,491  8,654  •  4,500  70,055  _+  18,703 
Thymidine incorporation (mean + SD) of CD34  + CD45RA  I~ CD71  l~ bone marrow cells (1,000 cells/well)  cultured for 8 d in serum-free  culture 
medium supplemented  with the indicated growth factors. 
Many mitotic figures and occasional cells with (pro) myelo- 
cyte morphology were seen at this stage.  At day 20 most 
cells had morphological features of (pro)  normoblast with 
distinct vacuoles in their cytoplasm that showed various degrees 
of hemoglobinization. Fully hemoglobinized enucleated red 
cells were not observed at any point in time, and it appeared 
that cells accumulated at a late normoblast-reticuloblast stage. 
Maintenance  of  CD34 +  CD7P  ~  Cells  in  Cultures  Sup. 
plemented with Recombinant Growth Factors.  The phenotype 
and  the  number  of cells  produced  in  serum-free culture 
medium supplemented with Ib3, IL-6, MGF, and Epo was 
analyzed in relation to the number of the purified CD34 + 
CD45RA  l~ CD71 l~ cells that were used to initiate the cul- 
tures. In eight separate experiments, it was found that the 
absolute number of CD34 + CD71 l~ calls present in the cul- 
tures between day 9 and 13 remained at input values (1.26 
_  0.4; mean  _+  SD), whereas the total number of cells in 
such cultures had increased between 16 and 4,700 times input 
values. This maintenance of CD34 + CD711~ cells in rapidly 
proliferating cultures was studied in more detail by resorting 
of CD34 + CD71 I~ cells from the cultures (Figs.  4 and 6). 
CD34 + CD71 l~ cells present in 10-d cultures in which most 
of the cells were rapidly proliferating were sorted (Fig. 6 A, 
box) and used to initiate secondary cultures. Analysis of sec- 
ondary  cultures  at  day  19  revealed  that  cells  with  the 
CD34 + CD71 l~ phenotype were still present at undimin- 
ished numbers. Such cells were sorted again (Fig.  6 B, box) 
and used to initiate tertiary cultures. This process was repeated 
two more times with very similar results in that on each oc- 
casion CD34 + CD711~  cells, capable of initiating subsequent 
cultures, were identified at seeded cell numbers (Fig. 4). Con- 
comitant production of cells  and maintenance of CD34 + 
CD711~ ceils was observed over a period of 5-7 wk and a 
total of four rounds of sorting and initiation of new cultures. 
After this time the absolute number of CD34 + CD71 l~ cells 
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(of which "~50% were recovered upon each round of staining 
and sorting) became too low to continue the experiments 
(<1,000  CD34 +  CD71 l~ ceUs). In  some experiments  the 
number of colony-forming cells and LTC-IC present in the 
suspension cultures was measured. On each occasion the total 
number of clonogenic calls and LTC-IC present correlated 
with the total number of CD34 + and CD34 + CD711~  calls, 
respectively (data not shown), at ratios similar to those ob- 
served at the start of the culture (Table  1). 
Discussion 
In this report we have used a novel procedure to purify 
primitive hematopoietic cells from human bone marrow to- 
gether with a serum-free culture system to study the biolog- 
ical properties of such calls in vitro. Cells with an immature 
CD34 + CD71 l~ phenotype were found to repeatedly gen- 
erate large numbers of erythroid progeny without decreasing 
in number. These observations are in agreement with several 
recent studies that have documented extensive Steel factor--de- 
pendent production of progenitor cells in the absence of ex- 
pansion of more primitive hematopoietic cells (2, 8, 10, 23), 
Our finding that cells with a  CD34 + CD71 l~ phenotype 
participate  in  cell  production while being  maintained in 
number suggest that the modest effect on very primitive he- 
matopoietic cells observed in these previous studies could be 
the result of inherent biological properties of such cells rather 
than their unresponsiveness to the added growth factors. The 
balance between production and maintenance of ceils that 
was observed in our system could thus be indicative of a bio- 
logical mechanism that limits expansion and yet avoids deple- 
tion of a primitive hematopoietic precursor cell pool. Several 
models for the observed CD34 + CD71 lo cell maintenance at 
a population, as well as at a single-cell  level, are currently 
being considered.  These models range from: (a) slow recruit- 109 
108, 
107, 
106, 
105, 
104 . 
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Figure 4.  Maintenance of primitive hematopoietic 
cells that produce extensive progeny. Kinetics of total 
cells (El) and CD34 + CD71  lo cells (m) in serum-free 
cultures supplemented with Ib3, Ib6, MGF, and Epo. 
Cultures  were  initiated  with  purified  CD34 + 
CD45RA  ]~ CD71to cells  from  (previously  frozen) 
bone marrow from two different organ donors (A and 
B). CD34 + CD71 lo cells were resorted from the cul- 
tures at the indicated time intervals. The total number 
of calls produced was calculated from the number of 
cells produced  in diluted  cultures  times the dilution 
factor;  the number of CD34 + CD71~o cells present 
at each time interval was calculated from the percentage 
of cells with this phenotype times the total number 
ofceUs in each culture. The actual number of CD34" 
CD71 ~~  cells recovered after sorting was typically 50% 
of this calculated figure as a result  of losses of cells 
upon staining  and sorting. 
ment of quiescent cells, and (b) balanced stir-renewal versus 
loss of cells, to (c) asymmetrical divisions (24), and (d) com- 
binations of the above. Although intrinsic factors in control 
of the overall size of a population of very primitive hemato- 
poietic cells in adult bone marrow are in agreement with the 
difficulties encountered to expand the absolute number of 
these cells in vitro, such restrictions do not explain their gener- 
ation in vivo. One possibility is that the production of these 
very primitive hematopoietic cells themselves is restricted to 
early stages of development (e.g., fetal life) and does not typi- 
cally occur in adult bone marrow. 
Our cell purification strategy was based on the use of FACS  | 
to selectively enrich for cells capable of producing colonies 
after 5 wk in long-term culture (LTC-IC), arguably the best 
in vitro assay for human hematopoietic stem cells that is cur- 
rently available  (2, 19, 21, 25). Previous studies have shown 
that LTC-IC can be differentially enriched in CD71 Z~ (26) 
and CD45RO + (12) cell fractions of normal bone marrow. 
These previous observations were confirmed and extended 
in the studies described here using a three-color immuno- 
fluorescence staining procedure. LTC-IC were highly enriched 
in the CD34 § CD45RA 1~ CD71 ]~ cell fraction, irrespective 
of whether bone marrow aspirates or bone marrow cells from 
vertebral bodies of (~d_mer) organ donors were analyzed (Table 
1). The finding that LTC-IC are enriched in the CD45RA ~~ 
cell fraction (this study) as well as in CD45RO + cell frac- 
tions, as reported previously (12), is in agreement with the 
proposed mutual exclusive expression of these CD45 isoforms 
on cells that express CD34 (12).  By sorting of cells on the 
basis of CD45RA,  CD71,  and CD34,  the rare subpopula- 
tions of cells that express CD34 could be separated into func- 
tionally distinct subpopulations (Table 1). The possibility of 
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Figure 5.  Erythroid differentia- 
tion of  primitive hematopoietic cells 
in culture. Phenotypic characteriza- 
tion  of cells in  cultures  initiated 
with purified  CD34 + CD45RA  Io 
CD71  l~ bone marrow cells at  the 
indicated time intervals. Serum-free 
culture medium was supplemented 
with  Ib3,  Ib6,  MGF,  and  Epo. 
Note that expression of CD71 pre- 
cedes loss of CD34 but that loss of 
CD34 precedes expression of glyco- 
phorin A. 
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Figure 6.  Sorting strategy used for maintenance of serum-free long- 
term cultures. Cells grown in serum-free culture medium supplemented 
with II:3, I1.,6, MGF, and Epo were analyzed on day 10 (.4), day 19 (B), 
day 31 (C),  and day 42 (D). CD34 + CD7110 cells (boxed area) were in 
each case sorted and used to initiate subsequent cultures (e.g., cells sorted 
from boxed area in A on day 10 gave rise to cells with phenotype shown 
in B at day 19, etc.). 
separating the majority of myeloid from erythroid progen- 
itors, as well as from LTC-IC, may offer advantages over pre- 
viously described purification  procedures (19,  27-29). 
The use of bone marrow cells from organ donors facili- 
tated the studies described in this paper. Not only were these 
cells em'iched  for CD34 + CD45RA  ~~ CD711~ cells and LTC- 
IC,  as compared with cells from marrow  aspirates (Fig.  2 
and Table 1), but the availability of relatively large numbers 
of (frozen) cells allowed reproducible experimentation with 
immature hematopoietic cells at cell numbers that would have 
been difficult to obtain from marrow aspirates.  Also, some 
consistent differences between normal marrow aspirates  and 
bone marrow cells from organ donors were observed, in that 
marrow aspirates  contained fewer low-density myeloid cells 
with an intermediate to high side scatter, and variable numbers 
of CD34 + CD45RA + CD711~ cells that coexpressed CD19 
and CD10 (30).  The latter were rare or absent in cell sus- 
pensions  from  vertebral  bodies  of organ  donors  (results 
not shown).  These differences between bone marrow cells 
from aspirates and vertebral bodies may be indicative of a func- 
tional  compartmentalization of hematopoietic tissue in vivo, 
perhaps in combination with some selection of more mature 
(less adherent)  cells  in  marrow  aspirates. 
Despite considerable enrichment of LTC-IC in a fraction 
of  CD34 +  CD45RA  I~  CD711~  cells,  LTC-IC  were  not 
purified to homogeneity (Table 1). Two alternative explana- 
tions for this observation were considered. LTC-IC could in- 
deed represent only a minor fraction of CD34 + CD45RA 1~ 
CD71 ]~ cells,  or, alternatively,  ine~dencies  in the LTC-IC 
assay system could underestimate the frequency of function- 
ally similar or identical cells (e.g.,  similar to purified Sea-1 +, 
Lin-, Thy-1  l~ cells in the mouse, of which <10% gave rise 
to colonies after 4 wk in routine long-term cultures [25]). 
Some interesting results were obtained when the functional 
in vitro properties of purified CD34 + CD45RA  l~ CD711~ 
were studied in more detail. To our surprise, we found that 
in the absence of growth factors CD34 + CD45RA  l~ CD71 l~ 
cells survived much better in serum-free culture medium than 
in serum-containing medium (Fig. 3). Furthermore, we ob- 
served that in serum-free cultures without stromal cells and 
with a much larger output of calls as compared with regular 
long-term cultures, cells with a CD34 + CD71 I~ phenotype 
were maintained at constant levels (Fig. 4). These results in- 
dicate that  the stromal cell requirement  for hematopoietic 
cell maintenance  in regular long-term cultures can be sub- 
stituted as previously reported by cytokines (22), serum-free 
medium (31), or a combination of cytokines and serum-free 
medium,  as reported here. 
Apart from studies on the biology of primitive hemato- 
poietic cells and further studies of erythropoiesis, the tech- 
niques and observations reported in this communication could 
have a number of practical applications in the development 
of gene transfer protocols and clinical  protocols aimed at ex- 
pansion of hematopoietic cells for diagnostic and therapeutic 
purposes. In view of such clinical  applications, it will be im- 
portant to obtain more information on the number and type 
of cells required by transplant recipients for short- and long- 
term hematopoietic reconstitution in relation to the number 
and type of cells  that  can now be produced in vitro. 
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